← Open Payments lookup

INGRID BROZE: Open Payments

NPI 1235870007 · FERNDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$735 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $182 · 2025 $735

Food & beverage: $664Education: $71
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$134
Neurocrine BioSciences, Inc.5$116
Lundbeck LLC4$95
Teva Pharmaceuticals USA, Inc.1$71
ABBVIE INC.3$68
Takeda Pharmaceuticals U.S.A., Inc.3$61
Axsome Therapeutics, Inc.2$56
Alkermes, Inc.2$52
Validus Pharmaceuticals LLC2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27

Products named: REXULTI, INGREZZA, TRINTELLIX, Auvelity, ARISTADA, VRAYLAR, RALDESY, ABILIFY ASIMTUFII.

Industry payments across MI — which companies pay providers there.